853
Views
8
CrossRef citations to date
0
Altmetric
ARTICLE

An Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa, Actaea racemosa) by the Natural Standard Research Collaboration

, PharmD & , MPH

REFERENCES

  • Amsterdam JD, Yao Y, Mao JJ, Soeller I, Rockwell K, Shults J. Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause. J Clin Psychopharmacol. 2009;29(5):478–483.
  • Anderson IB, Mullen WH, Meeker JE, Khojasteh Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996;124(8):726–734.
  • Antoine C, Liebens F, Carly B, Pastijn A, Rozenberg S. Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric. 2007;10(1):23–26.
  • Ashar BH, Rice TN, Sisson SD. Medical residents’ knowledge of dietary supplements. South. Med J 2008;101(10):996–1000.
  • Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu L, Jiao C, Liske E. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58(1):31–41.
  • Baillie N. Rasmussen P. Black and blue cohosh in labour. N.Z Med J 1997;110(1036):20–21.
  • Bai WP, Wang SY, Liu JL, Geng L, Hu LN, Zhang ZL, Chen SL, Zheng SR. Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms. Zhonghua Fu Chan Ke. Za Zhi. 2009;44(8):597–600.
  • Bebenek M, Kemmler W., von Stengel S, Engelke K, Kalender WA. Effect of exercise and Cimicifuga racemosa (CR BNO 1055) on bone mineral density, 10-year coronary heart disease risk, and menopausal complaints: the randomized controlled Training and Cimicifuga racemosa Erlangen (TRACE) study. Menopause. 2010;17(4):791–800.
  • Becker E, Letham T, Stoehr JD. Is black cohosh a safe and effective substitute for hormone replacement therapy? JAAPA. 2009;22(9):54–55.
  • Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2003;84(2–3):259–268.
  • Betz JM, Anderson L, Avigan MI Barnes J Farnsworth NR Gerden B Henderson L Kennelly EJ Koetter U Lessard S Dog TL McLaughlin M Naser B Osmers RG Pellicore LS Senior JR van Breemen RB Wuttke W Cardellina JH. Black cohosh: considerations of safety and benefit. Nutrition Today 2009;44(4):155–162.
  • Beuscher N, Reichert R. Cimicifuga racemosa L.—black cohosh. Zeit Phytother 1995;16:301–310.
  • Boblitz N, Schrader E, Henneicke-von Zepelin HH, et al. Benefit of a fixed drug combination containing St. John's wort and black cohosh for climacteric patients—results of a randomised clinical trial (poster presentation from 6th Annual Symposium on Complementary Health Care, Exeter, England, December 2–4, 1999). Focus Alt Comp Ther (FACT) 2000;5(1):85–86.
  • Bodinet C, Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause. 2004;11(3):281–289.
  • Booth NL, Nikolic D, van Breemen RB, Geller SE, Banuvar S, Shulman LP, Farnsworth NR. Confusion regarding anticoagulant coumarins in dietary supplements. Clin Pharmacol. Ther 2004;76(6):511–516.
  • Borrelli F, Ernst E. Cimicifuga racemosa: a systematic review of its clinical efficacy. Eur J Clin Pharmacol 2002;58(4):235–241.
  • Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet. Gynecol. 2008a;199(5):455–466.
  • Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol. Res 2008b;58(1):8–14.
  • Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010;66(4):333–343.
  • Borrelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci. 2003;73(10):1215–1229.
  • Borrelli F, Mascolo N, Russo A, et al. Cimicifuga racemosa: a systematic review of its clinical and pharmacological effects. 8th Annual Symposium on Complementary Health Care, 6th-8th December 2001 2001
  • Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1696–1708.
  • Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment—results of a large-scale, controlled, observational study. Maturitas 2007;57(4):405–414.
  • Bruno D, Feeney KJ. Management of postmenopausal symptoms in breast cancer survivors. Semin. Oncol. 2006;33(6):696–707.
  • Buettner C, Mukamal KJ, Gardiner P, Davis RB, Phillips RS, Mittleman MA. Herbal supplement use and blood lead levels of United States adults. J Gen. Intern. Med 2009;24(11):1175–1182.
  • Burdette JE, Chen SN, Lu ZZ, Xu H, White BE, Fabricant DS, Liu J, Fong HH, Farnsworth NR, Constantinou AI, van Breemen RB, Pezzuto JM, Bolton JL. Black cohosh (Cimicifuga racemosa L.) protects against menadione-induced DNA damage through scavenging of reactive oxygen species: bioassay-directed isolation and characterization of active principles. J Agric. Food Chem 2002;50(24):7022–7028.
  • Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, van Breemen RB, Farnsworth NR, Bolton JL. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric. Food Chem. 2003;51(19):5661–5670.
  • Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed. Pharmacother. 2002;56(6):283–288.
  • Carroll DG. Nonhormonal therapies for hot flashes in menopause. Am Fam. Physician 2006;73(3):457–464.
  • Centre for Reviews and Dissemination. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review (Structured abstract), Archives of Internal Medicine, 2006;166(14):1453–1465.
  • Cheema D, Coomarasamy A, El Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol. Obstet 2007;276(5): 463–469.
  • Chen SN, Fabricant DS, Pauli GF, Fong HH, Farnsworth NR. Synthesis of cimiracemate B, a phenylpropanoid found in Cimicifuga racemosa. Nat Prod Res 2005;19(3):287–290.
  • Chen SN, Lankin DC, Nikolic D, Fabricant DS, Lu ZZ, Ramirez B., van Breemen RB, Fong HH, Farnsworth NR, Pauli GF. Chlorination diversifies Cimicifuga racemosa triterpene glycosides. J Nat Prod 2007;70(6):1016–1023.
  • Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol. Hepatol. 2008;23(3):366–373.
  • Chow EC, Teo M, Ring JA, Chen JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008;188(7):420–422.
  • Chung DJ, Kim HY, Park KH, Jeong KA, Lee SK, Lee YI, Hur SE, Cho MS, Lee BS, Bai SW, Kim CM, Cho SH, Hwang JY, Park JH. Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms. Yonsei Med J 2007;48(2):289–294.
  • Cimicifuga racemosa Monograph. Altern. Med Rev 2003;8(2):186–189.
  • Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause. 2004;11(5):575–577.
  • Cybulska P, Thakur SD, Foster BC, Scott IM, Leduc RI, Arnason JT, Dillon JA. Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles. Sex Transm. Dis 2011;38(7): 667–671.
  • Daiber W. Menopause symptoms: success without hormones. Arztl Praxis 1983;35:1946–1947.
  • Davis VL, Jayo MJ, Ho A, Kotlarczyk MP, Hardy ML, Foster WG, Hughes CL. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer Res 2008;68(20):8377–8383.
  • Davis SR, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Bell RJ. Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause. 2010;17(5):1004–1009.
  • Dennehy CE. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health 2006;51(6):402–409.
  • Dennehy C, Tsourounis C, Bui L, King TL. The use of herbs by California midwives. J Obstet. Gynecol. Neonatal Nurs. 2010;39(6):684–693.
  • Dixon-Shanies D, Shaikh N. Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep. 1999;6(6):1383–1387.
  • Dog TL, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause. 2003;10(4):299–313.
  • Donnelly GF. Herbal efficacy: the case of black cohosh. Holist. Nurs Pract 2007;21(3):103.
  • Dugoua JJ, Seely D, Perri D, Koren G, Mills E. Safety and efficacy of black cohosh (Cimicifuga racemosa) during pregnancy and lactation. Can J Clin Pharmacol 2006;13(3):e257–e261.
  • Duker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 1991;57(5):420–424.
  • Dunbar K, Solga SF. Black cohosh, safety, and public awareness. Liver Int. 2007;27(7):1017–1018.
  • Ehrlich M, Rao J, Pabby A, Goldman MP. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid. Dermatol. Surg 2006;32(5): 618–625.
  • Einbond LS, Shimizu M, Ma H, Wu HA, Goldsberry S, Sicular S, Panjikaran M, Genovese G, Cruz E. Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem. Biophys. Res Commun. 2008;375(4):608–613.
  • Einbond LS, Shimizu M, Nuntanakorn P, Seter C, Cheng R, Jiang B, Kronenberg F, Kennelly EJ, Weinstein IB. Actein and a fraction of black cohosh potentiate antiproliferative effects of chemotherapy agents on human breast cancer cells. Planta Med 2006;72(13):1200–1206.
  • Einbond LS, Shimizu M, Xiao D, Nuntanakorn P, Lim JT, Suzui M, Seter C, Pertel T, Kennelly EJ, Kronenberg F, Weinstein IB. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res Treat. 2004;83(3):221–231.
  • Einbond LS, Soffritti M, Esposti DD, Park T, Cruz E, Su T, Wu HA, Wang X, Zhang YJ, Ham J, Goldberg IJ, Kronenberg F, Vladimirova A. Actein activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats. Fundam. Clin Pharmacol. 2009;23(3):311–321.
  • Einbond LS, Su T, Wu HA, Friedman R, Wang X, Jiang B, Hagan T, Kennelly EJ, Kronenberg F, Weinstein IB. Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Res 2007a;27(2):697–712.
  • Einbond LS, Su T, Wu HA, Friedman R, Wang X, Ramirez A, Kronenberg F, Weinstein IB. The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways. Int J Cancer 2007b;121(9):2073–2083.
  • Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 1996;25(2):149–153.
  • Ernst E, Chrubasik S. Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. Rheum. Dis Clin North Am 2000;26(1):13–27, vii.
  • Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005;51(4):397–404.
  • Freudenstein J, Bodinet C. Influence of an isopropanolic aqueous extract of Cimicifuga racemosae rhizoma on the proliferation of MCF-7 cells. 23rd International LOF-Symposium on Phytoestrogens, University of Ghent, Belgium (January 15, 1999).
  • Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2006;34(4):577–582.
  • Fugh-Berman A. “Bust enhancing” herbal products. Obstet. Gynecol. 2003;101(6):1345–1349.
  • Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52(5):587–595.
  • Garcia-Perez MA, Pineda B, Hermenegildo C, Tarin JJ, Cano A. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line. Fertil. Steril. 2009;91(4 Suppl):1347–1350.
  • Garita-Hernandez M, Calzado MA, Caballero FJ, Macho A, Munoz E, Meier B, Brattstrom A, Fiebich BL, Appel K. The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways. Planta Med 2006;72(4):317–323.
  • Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, Hedayat S, Nikolic D, Krause EC, Piersen CE, Bolton JL, Pauli GF, Farnsworth NR. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause. 2009;16(6):1156–1166.
  • Geller SE, Studee L. Contemporary alternatives to plant estrogens for menopause. Maturitas 2006;55 Suppl 1:S3–13.
  • Genazzani E, Sorrentino L. Vascular action of acteina: active constituent of Actaea racemosa L. Nature 1962;194(4828):544–545.
  • Gingrich PM, Fogel CI. Herbal therapy use by perimenopausal women. J Obstet. Gynecol. Neonatal Nurs. 2003;32(2):181–189.
  • Goda Y. Safety of health foods and importance of their origin. Yakugaku Zasshi 2008;128(6):837–838.
  • Godecke T, Nikolic D, Lankin DC, Chen SN, Powell SL, Dietz B, Bolton JL, van Breemen RB, Farnsworth NR, Pauli GF. Phytochemistry of cimicifugic acids and associated bases in Cimicifuga racemosa root extracts. Phytochem. Anal. 2009;20(2):120–133.
  • Gori L, Firenzuoli F. Is black cohosh a hepatotoxic medicinal herb? Forsch Komplement. Med (2006.) 2007;14(2):109–110.
  • Grippo AA, Hamilton B, Hannigan R, Gurley BJ. Metal content of ephedra-containing dietary supplements and select botanicals. Am J Health Syst. Pharm 2006;63(7):635–644.
  • Gunn TR, Wright IM. The use of black and blue cohosh in labour. N.Z Med J 1996;109(1032):410–411.
  • Gurley BJ, Barone GW, Williams DK, Carrier J, Breen P, Yates CR, Song PF, Hubbard MA, Tong Y, Cheboyina S. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos. 2006;34(1):69–74.
  • Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin. Pharmacol. Ther. 2005;77(5):415–426.
  • Gurley B, Hubbard MA, Williams DK, Thaden J, Tong Y, Gentry WB, Breen P, Carrier DJ, Cheboyina S. Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J Clin Pharmacol 2006;46(2):201–213.
  • Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SK. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol. Nutr Food Res 2008;52(7):755–763.
  • Guttuso T, Jr. Effective and clinically meaningful non-hormonal hot flash therapies. Maturitas 2012;72(1):6–12.
  • Hailemeskel B, Lee HJ, Thomhe H. Incidence of potential herb-drug interactions among herbal users. ASHP Midyear Clinical Meeting 2000;35:p-267e.
  • Haimov-Kochman R, Brzezinski A, Hochner-Celnikier D. Herbal remedies for menopausal symptoms: are we cautious enough? Eur. J Contracept. Reprod. Health Care 2008;13(2):133–137.
  • Hamburger M. New approaches in analyzing the pharmacological properties of herbal extracts. Proc. West Pharmacol. Soc 2007;50:156–161.
  • Hanna K, Day A, O'Neill S, Patterson C, Lyons-Wall P. Does scientific evidence support the use of non-prescription supplements for treatment of acute menopausal symptoms such as hot flushes? Nutrition & Dietetics 2005;62(4):138–151.
  • Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash.) 2000;40(2):234–242.
  • Hemachandra LP, Madhubhani P, Chandrasena R, Esala P, Chen SN, Main M, Lankin DC, Scism RA, Dietz BM, Pauli GF, Thatcher GR, Bolton JL. Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A). Cancer Prev. Res (Phila) 2012;5(1):73–81.
  • Hemmi H, Kitame F, Ishida N, et al. Inhibition of thymidine transport into phytohemagglutinin-stimulated lymphocytes by triterpenoids from Cimicifuga species. J Pharm Dyn 1979;2:339–349.
  • Hemmi H, Kusano G, Ishida N. Selective inhibition of nucleoside transport into mouse lymphoma L- 5178Y cells by cimicfugoside. J Pharmacobiodyn. 1980;3(12):636–642.
  • Herbal Medicinal Products Committee. Assessment of case reports connected to herbal medicinal products containing cimicifugae racemosa rhizoma (black cohosh, root). 2007.
  • Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44 Suppl 1:S59–S65.
  • He K, Zheng B, Kim CH, Rogers L, Zheng Q. Direct analysis and identification of triterpene glycosides by LC/MS in black cohosh, Cimicifuga racemosa, and in several commercially available black cohosh products. Planta Med 2000;66(7):635–640.
  • Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause. 2007;14(1):89–96.
  • Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull 2004;27(12):1970–1975.
  • Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Anticancer Res 2005;25(1A):139–147.
  • Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-mB 231 human breast cancer cells. In Vivo 2007;21(2):349–355.
  • Huang Y, Jiang B, Nuntanakorn P, Kennelly EJ, Shord S, Lawal TO, Mahady GB. Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro. Curr Drug Saf 2010;5(2):118–124.
  • Hunter A. Cimicifuga racemosa: pharmacology, clinical trials and clinical use. Eur J Herbal Med 1999;5(1):19–25.
  • Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause. 2003a;10(5):465–476.
  • Huntley A, Ernst E. A systematic review of the safety of black cohosh. Menopause 2003b;10(1):58–64.
  • Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol 2007;56(5 Suppl):S124-S126.
  • Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, Neugut AI, Grann VR. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19(10):2739–2745.
  • Jarry H, Harnischfeger G. Endocrine effects of constituents of Cimicifuga racemosa. 1. The effect on serum levels of pituitary hormones in ovariectomized rats. Planta Med 1985;51(1):46–49.
  • Jarry H, Harnischfeger G, Duker E. The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors. Planta Med 1985;51(4):316–319.
  • Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 2003;44 Suppl 1:S31–S38.
  • Jassim GA. Strategies for managing hot flashes. J Fam. Pract. 2011;60(6):333–339.
  • Jiang B, Yang H, Nuntanakorn P, Balick MJ, Kronenberg F, Kennelly EJ. The value of plant collections in ethnopharmacology: a case study of an 85-year-old black cohosh (Actaea racemosa L.) sample. J Ethnopharmacol. 2005;96(3):521–528.
  • Johnson BM, van Breemen RB. In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). Chem. Res Toxicol. 2003;16(7):838–846.
  • Joy D, Joy J, Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric. 2008;11(1):84–88.
  • Julia Molla MD, Garcia-Sanchez Y, Romeu Sarri A, Perez-lopez FR. Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women. Gynecol. Endocrinol. 2009;25(1):21–26.
  • Kanadys WM, Leszczynska-Gorzelak B, Oleszczuk J. Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms—review of clinical trials. Ginekol. Pol. 2008;79(4):287–296.
  • Kang HJ, Ansbacher R, Hammoud MM. Use of alternative and complementary medicine in menopause. Int. J Gynaecol. Obstet. 2002;79(3):195–207.
  • Kelley KW, Carroll DG. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J Am Pharm. Assoc. (2003.) 2010;50(5):e106-e115.
  • Kelly JP, Kaufman DW, Rosenberg L, Kelley K, Cooper SG, Mitchell AA. Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiol. Drug Saf 2005;14(12):837–842.
  • Kennelly EJ, Baggett S, Nuntanakorn P, Ososki AL, Mori SA, Duke J, Coleton M, Kronenberg F. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002;9(5):461–467.
  • Kim CD, Lee WK, Lee MH, Cho HS, Lee YK, Roh SS. Inhibition of mast cell-dependent allergy reaction by extract of black cohosh (Cimicifuga racemosa). Immunopharmacol Immunotoxicol. 2004;26(2):299–308.
  • Kistin SJ, Newman AD. Induction of labor with homeopathy: a case report. J Midwifery Womens Health 2007;52(3):303–307.
  • Kligler B. Black cohosh. Am. Fam. Physician 2003;68(1):114–116.
  • Koeda M, Aoki Y, Sakurai N, Nagai M. Studies on the Chinese crude drug “shoma.” IX. Three novel cyclolanostanol xylosides, cimicifugosides H-1, H-2 and H-5, from cimicifuga rhizome. Chem Pharm. Bull. (Tokyo) 1995;43(5):771–776.
  • Korn WD. Six month oral toxicity study with remifemin-granulate in rats followed by an 8-week recovery period, p 1. Hannover, Germany, International Bioresearch, 1991.
  • Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137(10):805–813.
  • Kupferer EM, Dormire SL, Becker H. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet. Gynecol. Neonatal Nurs. 2009;38(1):50–59.
  • Lehmann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl. Gynakol. 1988;110(10):611–618.
  • Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health 1998;7(5):525–529.
  • Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv. Ther 1998;15(1):45–53.
  • Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend. Based. Med 2002;11(2):163–174.
  • Liske E, Wustenberg P. Efficacy and safety of phytomedicines with particular references to Cimicifuga racemosa. J Med Assoc Thai 1998;Jan:s108.
  • Liske E, Wüstenberg P. Therapy of climacteric complaints with Cimicifuga racemosa: herbal medicine with clinically proven evidence [poster presentation]. Menopause 1998;5(4):250.
  • Liske E, Wüstenberg P, Boblitz N. Human-pharmacological investigations during treatment of climacteric complaints with Cimicifuga racemosa (Remifemin): No estrogen-like effects. ESCOP 2001;1:1.
  • Li W, Sun Y, Liang W, Fitzloff JF, van Breemen RB. Identification of caffeic acid derivatives in Actea racemosa (Cimicifuga racemosa, black cohosh) by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2003;17(9):978–982.
  • Liu J, Burdette JE, Xu H, Gu C., van Breemen RB, Bhat KP, Booth N, Constantinou AI, Pezzuto JM, Fong HH, Farnsworth NR, Bolton JL. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49(5):2472–2479.
  • Liu Z, Yang Z, Zhu M, Huo J. Estrogenicity of black cohosh (Cimicifuga racemosa) and its effect on estrogen receptor level in human breast cancer MCF-7 cells. Wei Sheng Yan. Jiu. 2001;30(2):77–80.
  • Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology. (Oxford) 2001;40(7):779–793.
  • Lontos S, Jones RM, Angus PW, Gow PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust. 2003;179(7):390–391.
  • Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause. 2008;15(4 Pt 1):655–660.
  • Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005;118 Suppl 12B:98–108.
  • Low Dog T, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause. 2003;10(4):299–313.
  • Lundstrom E, Christow A, Kersemaekers W, Svane G, Azavedo E, Soderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet. Gynecol. 2002;186(4):717–722.
  • Lundstrom E, Hirschberg AL, Soderqvist G. Digitized assessment of mammographic breast density—effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Maturitas 2011;70(4):361–364.
  • Lupu R, Mehmi I, Atlas E, Tsai MS, Pisha E, Oketch-Rabah HA, Nuntanakorn P, Kennelly EJ, Kronenberg F. Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Oncol. 2003;23(5):1407–1412.
  • Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl. 2006;12(6):989–992.
  • Maclennan AH. Evidence-based review of therapies at the menopause. Int. J Evid. Based. Healthc. 2009;7(2):112–123.
  • Mahady GB. Is black cohosh estrogenic? Nutr. Rev 2003;61(5 Pt 1):183–186.
  • Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008;15(4 Pt 1):628–638.
  • Mahady G, Low Dog T, Sarma DN, Giancaspro GI. Suspected black cohosh hepatotoxicity— causality assessment versus safety signal. Maturitas 2009;64(2):139–140.
  • Mahady G, Low Dog T, Sarma ND, Giancaspro GI, Griffiths J. The causal relationship between the use of black cohosh-containing products and hepatotoxicity. Menopause. 2010;17(5): 1088–1089.
  • Maki PM, Rubin LH, Fornelli D, Drogos L, Banuvar S, Shulman LP, Geller SE. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause. 2009;16(6):1167–1177.
  • Marotta F, Mao GS, Liu T, Chui DH, Lorenzetti A, Xiao Y, Marandola P. Anti-inflammatory and neuroprotective effect of a phytoestrogen compound on rat microglia. Ann N Y. Acad Sci 2006;1089:276–281.
  • Mazaro-Costa R, Andersen ML, Hachul H, Tufik S. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? J Sex Med 2010;7(11):3695–3714.
  • McBane SE. Easing vasomotor symptoms: Besides HRT, what works? JAAPA. 2008;21(4): 26–31.
  • McCormick M, Manoguerra A. Toxicity of pennyroyal oil: a case report and review [abstract]. Vet Human Toxicol 1988;30(4):347.
  • McFarlin BL, Gibson MH, O'Rear J, Harman P. A national survey of herbal preparation use by nurse-midwives for labor stimulation. Review of the literature and recommendations for practice. J Nurse Midwifery 1999;44(3):205–216.
  • McKenna DJ, Jones K, Humphrey S, Hughes K. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther Health Med 2001;7(3):93–100.
  • McKenzie SC, Rahman A. Bradycardia in a patient taking black cohosh. Med J Aust. 2010;193(8):479–481.
  • Mello NK. Commentary on black cohosh for the treatment of menopausal symptoms. Menopause. 2008;15(5):819–820.
  • Meyer S, Vogt T, Obermann EC, Landthaler M, Karrer S. Cutaneous pseudolymphoma induced by Cimicifuga racemosa. Dermatology 2007;214(1):94–96.
  • Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study. Br J Rheumatol 1996;35(9):874–878.
  • Minciullo PL. Causative relationship between asthenia and the intake of black cohosh. Phytomedicine 2009;16(8):800.
  • Minciullo PL, Saija A, Patafi M, Marotta G, Ferlazzo B, Gangemi S. Muscle damage induced by black cohosh (Cimicifuga racemosa). Phytomedicine 2006;13(1–2):115–118.
  • Mohamed ME, Frye RF. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab Dispos. 2011;39(9):1522–1528.
  • Mohamed MF, Tseng T, Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010;40(10):663–669.
  • Molla MD, Hidalgo-Mora JJ, Soteras MG. Phytotherapy as alternative to hormone replacement therapy. Front Biosci (Schol. Ed) 2011;3:191–204.
  • Moyad MA. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology 2002;59(4 Suppl 1):20–33.
  • Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol. Endocrinol. 2005;20(1):30–35.
  • Naser B, Liske E. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust. 2009;190(2):99.
  • Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte KU, Osmers R. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause. 2011;18(4):366–375.
  • Nash LI, Desindes S. Canadian consensus conference on menopause 2006 update. J Obstet Gynaecol Can 2006;28:S69–74.
  • Nasr A, Nafeh H. Influence of black cohosh (Cimicifuga racemosa) use by postmenopausal women on total hepatic perfusion and liver functions. Fertil. Steril. 2009;92(5):1780–1782.
  • Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern. Med 2006;166(14):1453–1465.
  • Neff MJ. NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause. Am Fam. Physician 2004;70(2):393–4, 396, 399.
  • Nesselhut T, Schellhase C, Dietrich R, et al. Investigations into the growth-inhibitive efficacy of phytopharmacopia with estrogen-like influences on mammary gland carcinoma cells (translated from German). Arch Gynecol Obstet 1993;254:817–818.
  • Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145(12):869–879.
  • Ng SS, Figg WD. Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice. Anticancer Res 2003;23(5A):3585–3590.
  • Nisslein T, Freudenstein J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner. Metab 2003;21(6):370–376.
  • Nisslein T, Freudenstein J. Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells. Toxicol. Lett. 2004;150(3):271–275.
  • Nisslein T, Freudenstein J. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma. Planta Med 2007;73(4):318–322.
  • Noguchi M, Nagai M, Koeda M, Nakayama S, Sakurai N, Takahira M, Kusano G. Vasoactive effects of cimicifugic acids C and D, and fukinolic acid in cimicifuga rhizome. Biol Pharm Bull 1998;21(11):1163–1168.
  • Nuntanakorn P, Jiang B, Einbond LS, Yang H, Kronenberg F, Weinstein IB, Kennelly EJ. Polyphenolic constituents of Actaea racemosa. J Nat Prod 2006;69(3):314–318.
  • Nuntanakorn P, Jiang B, Yang H, Cervantes-Cervantes M, Kronenberg F, Kennelly EJ. Analysis of polyphenolic compounds and radical scavenging activity of four American Actaea species. Phytochem. Anal. 2007;18(3):219–228.
  • Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2207–2213.
  • Oerter Klein K, Janfaza M, Wong JA, Chang RJ. Estrogen bioactivity in fo-ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay. J Clin Endocrinol. Metab 2003;88(9):4077–4079.
  • Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24(2):448–461.
  • Onorato J, Henion JD. Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction. Anal. Chem 2001;73(19):4704–4710.
  • Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet. Gynecol 2005;105(5 Pt 1):1074–1083.
  • Overk CR, Yao P, Chen S, Deng S, Imai A, Main M, Schinkovitz A, Farnsworth NR, Pauli GF, Bolton JL. High-content screening and mechanism-based evaluation of estrogenic botanical extracts. Comb. Chem. High Throughput. Screen. 2008;11(4):283–293.
  • Pade D, Stavchansky S. Selection of bioavailability markers for herbal extracts based on in silico descriptors and their correlation to in vitro permeability. Mol. Pharm. 2008;5(4):665–671.
  • Palacio C, Masri G, Mooradian AD. Black cohosh for the management of menopausal symptoms : a systematic review of clinical trials. Drugs Aging 2009;26(1):23–36.
  • Pang X, Cheng J, Krausz KW, Guo DA, Gonzalez FJ. Pregnane X receptor-mediated induction of Cyp3a by black cohosh. Xenobiotica 2011;41(2):112–123.
  • Patel NM, Derkits RM. Possible increase in liver enzymes secondary to atorvastatin and black cohosh administration. J Pharm Pract 2007;20:341–346.
  • Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health Syst. Pharm 1999;56(14):1400–1402.
  • Petho A. Climacteric complaints are often helped with black cohosh. Ärztliche Praxis 1987;47:1551–1553.
  • Pierard S, Coche JC, Lanthier P, Dekoninck X, Lanthier N, Rahier J, Geubel AP. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur J Gastroenterol Hepatol. 2009;21(8):941–945.
  • Pineda B, Garcia-Perez MA, Vazquez F, Julia MD, Tarin JJ, Hermenegildo C, Cano A. No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells. Eur J Obstet. Gynecol. Reprod. Biol. 2009;144(1):93–94.
  • Pinkerton JV, Stovall DW, Kightlinger RS. Advances in the treatment of menopausal symptoms. Womens Health (Lond Engl.) 2009;5(4):361–384.
  • Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol. 2006;24(18):2836–2841.
  • Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004;22(4):515–521.
  • Raus K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause. 2006;13(4):678–691.
  • Reame NE, Lukacs JL, Padmanabhan V, Eyvazzadeh AD, Smith YR, Zubieta JK. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause. 2008;15(5):832–840.
  • Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer 2007;120(7):1523–1528.
  • Rhyu MR, Lu J, Webster DE, Fabricant DS, Farnsworth NR, Wang ZJ. Black cohosh (Actaea racemosa Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor. J Agric. Food Chem 2006;54(26):9852–9857.
  • Richardson MK. Black cohosh…a cautionary tale! Menopause. 2008;15(4 Pt 1):583.
  • Roberts H. Safety of herbal medicinal products in women with breast cancer. Maturitas 2010;66(4):363–369.
  • Rock E, DeMichele A. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 2003;133(11 Suppl 1):3785S–3793S.
  • Ross SM. Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms. Holist. Nurs. Pract. 2012;26(1):58–61.
  • Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R, Bartsch HH. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints—a prospective observational study. Gynecol Endocrinol. 2011;27(10):844–848.
  • Rotem C, Kaplan B. Phyto-female complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol. 2007;23(2):117–122.
  • Roush K. Managing menopausal symptoms. Am J Nurs. 2012;112(6):28–35.
  • Sakurai N., Nagai M. Chemical constituents of original plants of Cimicifugae rhizoma in Chinese medicine. Yakugaku Zasshi 1996;116(11):850–865.
  • Sakurai N, Wu JH, Sashida Y, Mimaki Y, Nikaido T, Koike K, Itokawa H, Lee KH. Anti-AIDS agents. Part 57: Actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins. Bioorg. Med Chem. Lett. 2004;14(5):1329–1332.
  • Sammartino A, Tommaselli GA, Gargano V., di Carlo C, Attianese W, Nappi C. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Gynecol Endocrinol. 2006;22(11):646–650.
  • Sarma ND, Giancaspro GI, Griffiths J, Dog TL. Black cohosh…more data, please! Menopause. 2011;18(4):350–351.
  • Schmid D, Woehs F, Svoboda M, Thalhammer T, Chiba P, Moeslinger T. Aqueous extracts of Cimicifuga racemosa and phenolcarboxylic constituents inhibit production of proinflammatory cytokines in LPS-stimulated human whole blood. Can J Physiol Pharmacol. 2009;87(11):963–972.
  • Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol. 2003;149(4):351–362.
  • Seidlova-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 2003;44 Suppl 1:S39-S50.
  • Sevior DK, Hokkanen J, Tolonen A, Abass K, Tursas L, Pelkonen O, Ahokas JT. Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail. Xenobiotica 2010;40(4):245–254.
  • Shah D, Agrawal S. Vasomotor symptoms: viewpoint from the Indian subcontinent and management of a common menopausal problem. Semin. Reprod. Med 2010;28(5):388–395.
  • Shahin AY, Ismail AM, Shaaban OM. Supplementation of clomiphene citrate cycles with Cimicifuga racemosa or ethinyl oestradiol—a randomized trial. Reprod. Biomed. Online. 2009;19(4):501–507.
  • Shahin AY, Ismail AM, Zahran KM, Makhlouf AM. Adding phytoestrogens to clomiphene induction in unexplained infertility patients—a randomized trial. Reprod. Biomed. Online. 2008;16(4):580–588.
  • Shams T, Setia MS, Hemmings R, McCusker J, Sewitch M, Ciampi A. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. Altern. Ther Health Med 2010;16(1):36–44.
  • Shao Y, Harris A, Wang M, Zhang H, Cordell GA, Bowman M, Lemmo E. Triterpene glycosides from Cimicifuga racemosa. J Nat Prod 2000;63(7):905–910.
  • Shen W, Stearns V. Treatment strategies for hot flushes. Expert. Opin. Pharmacother. 2009;10(7):1133–1144.
  • Shibata M, Ikoma M, Onoda M, Sato F, Sakurai N. Pharmacological studies on the Chinese crude drug “Shoma”. III. Central depressant and antispasmodic actions of Cimicifuga rhizoma, Cimicifuga simplex Wormsk (author's transl). Yakugaku Zasshi 1980;100(11):1143–1150.
  • Shi S, Klotz U. Drug interactions with herbal medicines. Clin Pharmacokinet. 2012;51(2):77–104.
  • Shord SS, Shah K, Lukose A. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther 2009;8(3):208–227.
  • Shou C, Li J, Liu Z. Complementary and alternative medicine in the treatment of menopausal symptoms. Chin J Integr Med 2011;17(12):883–888.
  • Shulman LP, Banuvar S, Fong HH, Farnsworth NR. Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover. Fitoterapia 2011;82(1):88–91.
  • Shuster J. Heparin and thrombocytopenia. Black cohosh root? Chasteberry tree? Seizures! Hosp Pharm 1996;31:1553–1554.
  • Siess VM, Seybold G. Studies on the effects of Pulsatilla pratensis, Cimicifuga racemosa and Aristolochia clematitis on the estrus in infantile and castrated white mice. Arzneimittelforschung 1960;10:514–520.
  • Spangler L, Newton KM, Grothaus LC, Reed SD, Ehrlich K, LaCroix AZ. The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin. Maturitas 2007;57(2):195–204.
  • Stoll W. Phytotherapeutikum beeinflusst atrophisches Vaginal epithel. Doppelblindversuch Cimicifuga vs. Oestrogenpraeparat [Phytopharmaceutical influences on atrophic vaginal epithelium. Double-blind study on Cimicifuga vs. an estrogen preparation]. Therapeutickon 1987;1:23–32.
  • Stolze H. An alternative to treat menopausal complaints. Gynecologie 1982;1:14–16.
  • Struck D, Tegtmeier M, Harnischfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Med 1997;63:289–290.
  • Stute P, Nisslein T, Gotte M, Kamischke A, Kiesel L, Klockenbusch W. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro. Maturitas 2007;57(4):382–391.
  • Takahira M, Kusano A, Shibano M, Kusano G, Koizumi K, Suzuki R, Kim HS, Wataya Y, Takahara M. Antimalarial activity and nucleoside transport inhibitory activity of the triterpenic constituents of Cimicifuga spp. Biol Pharm Bull 1998;21(8):823–828.
  • Tamaki H, Satoh H, Hori S, Ohtani H, Sawada Y. Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure-inhibitory potency relationship of isoflavonoids. Drug Metab Pharmacokinet. 2010;25(2):170–179.
  • Teschke R. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust. 2009a;190(2):99–100.
  • Teschke R. A U.S. review determined that black cohosh products should be labeled with a cautionary statement. Menopause. 2009b;16(1):214–215.
  • Teschke R. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause. 2010;17(2):426–440.
  • Teschke R, Bahre R, Fuchs J, Wolff A. Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause. 2009;16(5):956–965.
  • Teschke R, Bahre R, Genthner A, Fuchs J, Schmidt-Taenzer W, Wolff A. Suspected black cohosh hepatotoxicity–challenges and pitfalls of causality assessment. Maturitas 2009;63(4):302–314.
  • Teschke R, Schmidt-Taenzer W, Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol. Drug Saf 2011;20(6):567–582.
  • Teschke R, Schwarzenbock A, Hennermann KH. Toxic liver disease due to drugs, herbs and dietary supplements: diagnostic approaches. Z. Gastroenterol. 2007;45(2):195–208.
  • Teschke R, Schwarzenboeck A. Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 2009;16(1):72–84.
  • Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol. 2011;10(3):249–259.
  • Thacker HL. Assessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal women. J Womens Health (Larchmt.) 2011;20(7):1007–1016.
  • Thomsen M, Schmidt M. Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated. J Altern. Complement Med 2003;9(3):337–340.
  • Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet. Gynecol. 2006;107(2 Pt 1):247–255.
  • Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag. Care Pharm. 2008;14(3 Suppl):14–19.
  • van Breemen RB, Liang W, Banuvar S, Shulman LP, Pang Y, Tao Y, Nikolic D, Krock KM, Fabricant DS, Chen SN, Hedayat S, Bolton JL, Pauli GF, Piersen CE, Krause EC, Geller SE, Farnsworth NR. Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh. Clin Pharmacol. Ther 2010;87(2):219–225.
  • van de Meerendonk HW, van Hunsel FP, van der Wiel HE. Autoimmune hepatitis induced by Actaea racemosa. Side effects of an herb extract. Ned. Tijdschr. Geneeskd. 2009;153(6):246–249.
  • van der Sluijs CP, Bensoussan A, Chang S, Baber R. A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause. 2009;16(2):336–344.
  • Vannacci A, Lapi F, Gallo E, Vietri M, Toti M, Menniti-Ippolito F, Raschetti R, Firenzuoli F, Mugelli A. A case of hepatitis associated with long-term use of Cimicifuga racemosa. Altern. Ther Health Med 2009;15(3):62–63.
  • Verhoeven MO, van der Mooren MJ, van de Weijer PH, Verdegem PJ, van der Burgt LM, Kenemans P. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause. 2005;12(4):412–420.
  • Vermes G, Banhidy F, Acs N. The effects of remifemin on subjective symptoms of menopause. Adv. Ther 2005;22(2):148–154.
  • Viereck V, Grundker C, Friess SC, Frosch KH, Raddatz D, Schoppet M, Nisslein T, Emons G, Hofbauer LC. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J Bone Miner. Res 2005;20(11):2036–2043.
  • Villaseca P. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric. 2012;15(2):115–124.
  • Vorberg G. Treatment of menopause symptoms. ZFA 1984;60:626–629.
  • Walji R, Boon H, Guns E, Oneschuk D, Younus J. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support. Care Cancer 2007;15(8):913–921.
  • Wang YJ, Dou J, Cross KP, Valerio LG, Jr. Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms. Regul. Toxicol. Pharmacol. 2011;59(1):111–124.
  • Wang HK, Sakurai N, Shih CY, Lee KH. LC/TIS-MS fingerprint profiling of Cimicifuga species and analysis of 23-Epi-26-deoxyactein in Cimicifuga racemosa commercial products. J Agric. Food Chem 2005;53(5):1379–1386.
  • Wanwimolruk S, Wong K, Wanwimolruk P. Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol. Drug Interact. 2009;24(1):17–35.
  • Warnecke G. Using phyto-treatment to influence menopause symptoms. Med Welt 1985;36:871–874.
  • Wende K, Mugge C, Thurow K, Schopke T, Lindequist U. Actaeaepoxide 3-O-beta-d-xylopyranoside, a new cycloartane glycoside from the rhizomes of Actaea racemosa (Cimicifuga racemosa). J Nat Prod 2001;64(7):986–989.
  • Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2002;177(8):440–443.
  • Willhite LA. O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21(4):464–480.
  • Wojcikowski K, Stevenson L, Leach D, Wohlmuth H, Gobe G. Antioxidant capacity of 55 medicinal herbs traditionally used to treat the urinary system: a comparison using a sequential three-solvent extraction process. J Altern Complement Med 2007;13(1):103–109.
  • Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. Gynecol. Endocrinol. 2009;25(3):166–174.
  • Woo KC, Park YS, Jun DJ, Lim JO, Baek WY, Suh BS, Kim KT. Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 2004;309(2):641–649.
  • Wuttke W, Gorkow C, Seidlova-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause. 2006;13(2):185–196.
  • Wuttke W, Seidlova-Wuttke D. News about Black cohosh. Maturitas 2012;71(2):92–93.
  • Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44 Suppl 1:S67–S77.
  • Yang CL, Chik SC, Li JC, Cheung BK, Lau AS. Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages. J Med Chem 2009;52(21):6707–6715.
  • Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 1998;217(3):369–378.
  • Zepelin HH, Meden H, Kostev K, Schroder-Bernhardi D, Stammwitz U, Becher H. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 2007;45(3):143–154.
  • Zhang L, Khan IA, Willett KL, Foran CM. In vivo effects of black cohosh and genistein on estrogenic activity and lipid peroxidation in Japanese Medaka (Oryzias latipes). J Herb. Pharmacother. 2003;3(3):33–50.
  • Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G. Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem. Mol. Biol 2002;80(1):125–130.
  • Zimmermann R, Witte A, Voll RE, Strobel J, Frieser M. Coagulation activation and fluid retention associated with the use of black cohosh: a case study. Climacteric. 2010;13(2): 187–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.